Cargando…

Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines

BACKGROUND: H-cadherin (CDH13) is commonly downregulated through promoter methylation in various cancers. However, the role of CDH13 promoter methylation status in patients with colorectal cancer (CRC) remains to be clarified. METHODS: Eligible articles were identified from online electronic databas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Meng, Huang, Tao, Li, Jinyun, Zhou, Chongchang, Yang, Ping, Ni, Chao, Chen, Si
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287966/ https://www.ncbi.nlm.nih.gov/pubmed/28121942 http://dx.doi.org/10.1097/MD.0000000000005956

Ejemplares similares

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies
por: Zhu, Linhai, et al.
Publicado: (2016)

Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA)
por: Zhan, Leyun, et al.
Publicado: (2017)

Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract: A systematic meta-analysis with PRISMA guidelines
por: Wang, Xiaowei, et al.
Publicado: (2017)

P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA
por: Tang, Yin, et al.
Publicado: (2017)

Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis
por: Long, Yuming, et al.
Publicado: (2021)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines
por: Guan, Xiuwen, et al.
Publicado: (2016)

Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis
por: Chen, Xiao-Dong, et al.
Publicado: (2016)

No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2017)

Menopausal status and the risk of lung cancer in women: A PRISMA-compliant meta-analysis
por: Min, Lingfeng, et al.
Publicado: (2017)

The risks of hematological toxicities of nivolumab in cancer patients: A PRISMA-compliant meta-analysis
por: Shi, Zuolin, et al.
Publicado: (2022)

Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients: A prisma-compliant meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2017)

Prognostic value of MSI2 expression in human malignancies: A PRISMA-compliant meta-analysis
por: Wu, Wei, et al.
Publicado: (2022)

Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines
por: Song, Qi, et al.
Publicado: (2020)

The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis
por: Zhang, Jie, et al.
Publicado: (2016)

The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis
por: Gao, Guangyu, et al.
Publicado: (2020)

Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer
por: Li, Jinyun, et al.
Publicado: (2017)

Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review
por: Liu, Wei, et al.
Publicado: (2016)

PRISMA—Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients
por: Xie, Shang, et al.
Publicado: (2015)

Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
por: Zhang, Zongxin, et al.
Publicado: (2017)

A PRISMA assessment of the reporting quality of systematic reviews of nursing published in the Cochrane Library and paper-based journals
por: Zhang, Juxia, et al.
Publicado: (2019)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA)
por: Liu, Rui, et al.
Publicado: (2015)

Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis
por: Xia, Jun, et al.
Publicado: (2017)

Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)
por: Jayadevappa, Ravishankar, et al.
Publicado: (2017)

Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2018)

Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis
por: Wang, Qinjing, et al.
Publicado: (2022)

Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer
por: Hu, Jing, et al.
Publicado: (2016)

Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer?
por: He, Wanbin, et al.
Publicado: (2017)

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance
por: Li, Jinyun, et al.
Publicado: (2018)

Long-Term Coffee Consumption and Risk of Gastric Cancer: A PRISMA-Compliant Dose–Response Meta-Analysis of Prospective Cohort Studies
por: Zeng, Shao-Bo, et al.
Publicado: (2015)

Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
por: Qixing, Mao, et al.
Publicado: (2015)

Hsa_circ_0002320: a novel clinical biomarker for colorectal cancer prognosis
por: Yang, Ning, et al.
Publicado: (2020)

S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials
por: Zhong, Sheng, et al.
Publicado: (2017)

Association of cytotoxic T lymphocyte-associated protein 4 gene -1772T/C polymorphism with gastric cancer risk: A prisma-compliant meta-analysis
por: Zhuo, Chenyi, et al.
Publicado: (2020)

Diagnostic value of exosome derived long noncoding RNA in gastric cancer in Chinese population: A PRISMA-compliant systematic review and meta-analysis
por: Zhu, Kangle, et al.
Publicado: (2021)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

DNA methylation patterns–based subtype distinction and identification of soft tissue sarcoma prognosis
por: Li, Kai, et al.
Publicado: (2021)

The Efficacy and Safety of Chemotherapy in Patients With Nonsmall Cell Lung Cancer and Interstitial Lung Disease: A PRISMA-Compliant Bayesian Meta-Analysis and Systematic Review
por: Chen, Yu Jie, et al.
Publicado: (2015)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhou, Jian-Guo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uoslqo9b7np766tok1uk1gicpg